Analyst consensus rating
Neurogene Analyst Rating: Strong Buy
Direct answer
Neurogene's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $77.63.
Forecast evidence checked November 21, 2026.
Get free Neurogene email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $22.15
- Average price target
- $77.63
- High price target
- $166.00
- Low price target
- $46.00
- Low target gap
- +107.7%
- Target upside
- +250.5%
- High target gap
- +649.4%
- Target range width
- 541.8%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- November 21, 2026
- Valid through
- November 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Neurogene?
Neurogene has a verified Strong Buy consensus. The same dataset has an average price target of $77.63.
How far are Neurogene's low and high targets from the recorded price?
The low target implies +107.7%, while the high target implies +649.4%.
How many analysts are included in Neurogene's consensus?
The verified consensus includes 8 analysts.
How is Neurogene's target upside or downside calculated?
The average target of $77.63 is divided by the recorded price of $22.15, then one is subtracted to produce +250.5%. This does not guarantee a future return.
When was Neurogene's analyst forecast verified?
The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.